 | • レポートコード：GIR-107A14276 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ハンチントン病タンパク質のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ハンチントン病タンパク質の種類別市場規模（NI-302、NLF-HD、P-301905、IONIS-HTTRx、その他）、用途別市場規模（アルツハイマー病、ケネディ病、脊髄小脳性運動失調症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ハンチントン病タンパク質の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：AFFiRiS AG、Ionis Pharmaceuticals, Inc.、Neurimmune Holding AG、nLife Therapeutics, S.L.、reMYND NV、Sangamo BioSciences, Inc.、UniQure N.V.、Voyager Therapeutics, Inc.、Vybion, Inc.、WAVE Life Sciences Ltd. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：NI-302、NLF-HD、P-301905、IONIS-HTTRx、その他 ・用途別分析2016年-2026年：アルツハイマー病、ケネディ病、脊髄小脳性運動失調症、その他 ・ハンチントン病タンパク質の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ハンチントン病タンパク質のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ハンチントン病タンパク質のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ハンチントン病タンパク質の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ハンチントン病タンパク質の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Huntington Disease Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Huntington Disease Protein size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Huntington Disease Protein market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Huntington Disease Protein market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
NI-302
NLF-HD
P-301905
IONIS-HTTRx
Others
Market segment by Application can be divided into
Alzheimer’s Disease
Kennedy’s Disease
Spinocerebellar Ataxia
Others
The key market players for global Huntington Disease Protein market are listed below:
AFFiRiS AG
Ionis Pharmaceuticals, Inc.
Neurimmune Holding AG
nLife Therapeutics, S.L.
reMYND NV
Sangamo BioSciences, Inc.
UniQure N.V.
Voyager Therapeutics, Inc.
Vybion, Inc.
WAVE Life Sciences Ltd.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Huntington Disease Protein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Huntington Disease Protein, with price, sales, revenue and global market share of Huntington Disease Protein from 2019 to 2021.
Chapter 3, the Huntington Disease Protein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Huntington Disease Protein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Huntington Disease Protein market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Huntington Disease Protein sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Huntington Disease Protein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Huntington Disease Protein Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 NI-302
1.2.3 NLF-HD
1.2.4 P-301905
1.2.5 IONIS-HTTRx
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Huntington Disease Protein Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Alzheimer’s Disease
1.3.3 Kennedy’s Disease
1.3.4 Spinocerebellar Ataxia
1.3.5 Others
1.4 Global Huntington Disease Protein Market Size & Forecast
1.4.1 Global Huntington Disease Protein Sales in Value (2016-2026))
1.4.2 Global Huntington Disease Protein Sales in Volume (2016-2026)
1.4.3 Global Huntington Disease Protein Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Huntington Disease Protein Production Capacity Analysis
1.5.1 Global Huntington Disease Protein Total Production Capacity (2016-2026)
1.5.2 Global Huntington Disease Protein Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Huntington Disease Protein Market Drivers
1.6.2 Huntington Disease Protein Market Restraints
1.6.3 Huntington Disease Protein Trends Analysis
2 Manufacturers Profiles
2.1 AFFiRiS AG
2.1.1 AFFiRiS AG Details
2.1.2 AFFiRiS AG Major Business
2.1.3 AFFiRiS AG Huntington Disease Protein Product and Services
2.1.4 AFFiRiS AG Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Ionis Pharmaceuticals, Inc.
2.2.1 Ionis Pharmaceuticals, Inc. Details
2.2.2 Ionis Pharmaceuticals, Inc. Major Business
2.2.3 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product and Services
2.2.4 Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Neurimmune Holding AG
2.3.1 Neurimmune Holding AG Details
2.3.2 Neurimmune Holding AG Major Business
2.3.3 Neurimmune Holding AG Huntington Disease Protein Product and Services
2.3.4 Neurimmune Holding AG Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 nLife Therapeutics, S.L.
2.4.1 nLife Therapeutics, S.L. Details
2.4.2 nLife Therapeutics, S.L. Major Business
2.4.3 nLife Therapeutics, S.L. Huntington Disease Protein Product and Services
2.4.4 nLife Therapeutics, S.L. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 reMYND NV
2.5.1 reMYND NV Details
2.5.2 reMYND NV Major Business
2.5.3 reMYND NV Huntington Disease Protein Product and Services
2.5.4 reMYND NV Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Sangamo BioSciences, Inc.
2.6.1 Sangamo BioSciences, Inc. Details
2.6.2 Sangamo BioSciences, Inc. Major Business
2.6.3 Sangamo BioSciences, Inc. Huntington Disease Protein Product and Services
2.6.4 Sangamo BioSciences, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 UniQure N.V.
2.7.1 UniQure N.V. Details
2.7.2 UniQure N.V. Major Business
2.7.3 UniQure N.V. Huntington Disease Protein Product and Services
2.7.4 UniQure N.V. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Voyager Therapeutics, Inc.
2.8.1 Voyager Therapeutics, Inc. Details
2.8.2 Voyager Therapeutics, Inc. Major Business
2.8.3 Voyager Therapeutics, Inc. Huntington Disease Protein Product and Services
2.8.4 Voyager Therapeutics, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Vybion, Inc.
2.9.1 Vybion, Inc. Details
2.9.2 Vybion, Inc. Major Business
2.9.3 Vybion, Inc. Huntington Disease Protein Product and Services
2.9.4 Vybion, Inc. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 WAVE Life Sciences Ltd.
2.10.1 WAVE Life Sciences Ltd. Details
2.10.2 WAVE Life Sciences Ltd. Major Business
2.10.3 WAVE Life Sciences Ltd. Huntington Disease Protein Product and Services
2.10.4 WAVE Life Sciences Ltd. Huntington Disease Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Huntington Disease Protein Sales by Manufacturer
3.1 Global Huntington Disease Protein Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Huntington Disease Protein Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Huntington Disease Protein
3.4 Market Concentration Rate
3.4.1 Top 3 Huntington Disease Protein Manufacturer Market Share
3.4.2 Top 6 Huntington Disease Protein Manufacturer Market Share
3.5 Global Huntington Disease Protein Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Huntington Disease Protein Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Huntington Disease Protein Market Size by Region
4.1.1 Global Huntington Disease Protein Sales in Volume by Region (2016-2026)
4.1.2 Global Huntington Disease Protein Revenue by Region (2016-2026)
4.2 North America Huntington Disease Protein Revenue (2016-2026)
4.3 Europe Huntington Disease Protein Revenue (2016-2026)
4.4 Asia-Pacific Huntington Disease Protein Revenue (2016-2026)
4.5 South America Huntington Disease Protein Revenue (2016-2026)
4.6 Middle East and Africa Huntington Disease Protein Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Huntington Disease Protein Sales in Volume by Type (2016-2026)
5.2 Global Huntington Disease Protein Revenue by Type (2016-2026)
5.3 Global Huntington Disease Protein Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Huntington Disease Protein Sales in Volume by Application (2016-2026)
6.2 Global Huntington Disease Protein Revenue by Application (2016-2026)
6.3 Global Huntington Disease Protein Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Huntington Disease Protein Sales by Type (2016-2026)
7.2 North America Huntington Disease Protein Sales by Application (2016-2026)
7.3 North America Huntington Disease Protein Market Size by Country
7.3.1 North America Huntington Disease Protein Sales in Volume by Country (2016-2026)
7.3.2 North America Huntington Disease Protein Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Huntington Disease Protein Sales by Type (2016-2026)
8.2 Europe Huntington Disease Protein Sales by Application (2016-2026)
8.3 Europe Huntington Disease Protein Market Size by Country
8.3.1 Europe Huntington Disease Protein Sales in Volume by Country (2016-2026)
8.3.2 Europe Huntington Disease Protein Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Huntington Disease Protein Sales by Type (2016-2026)
9.2 Asia-Pacific Huntington Disease Protein Sales by Application (2016-2026)
9.3 Asia-Pacific Huntington Disease Protein Market Size by Region
9.3.1 Asia-Pacific Huntington Disease Protein Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Huntington Disease Protein Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Huntington Disease Protein Sales by Type (2016-2026)
10.2 South America Huntington Disease Protein Sales by Application (2016-2026)
10.3 South America Huntington Disease Protein Market Size by Country
10.3.1 South America Huntington Disease Protein Sales in Volume by Country (2016-2026)
10.3.2 South America Huntington Disease Protein Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Huntington Disease Protein Sales by Type (2016-2026)
11.2 Middle East & Africa Huntington Disease Protein Sales by Application (2016-2026)
11.3 Middle East & Africa Huntington Disease Protein Market Size by Country
11.3.1 Middle East & Africa Huntington Disease Protein Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Huntington Disease Protein Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Huntington Disease Protein Typical Distributors
12.3 Huntington Disease Protein Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Huntington Disease Protein Revenue by Type, (USD Million), 2021-2026
Table 2. Global Huntington Disease Protein Revenue by Application, (USD Million), 2021-2026
Table 3. AFFiRiS AG Basic Information, Manufacturing Base and Competitors
Table 4. AFFiRiS AG Major Business
Table 5. AFFiRiS AG Huntington Disease Protein Product and Services
Table 6. AFFiRiS AG Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Ionis Pharmaceuticals, Inc. Major Business
Table 9. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Product and Services
Table 10. Ionis Pharmaceuticals, Inc. Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Neurimmune Holding AG Basic Information, Manufacturing Base and Competitors
Table 12. Neurimmune Holding AG Major Business
Table 13. Neurimmune Holding AG Huntington Disease Protein Product and Services
Table 14. Neurimmune Holding AG Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. nLife Therapeutics, S.L. Basic Information, Manufacturing Base and Competitors
Table 16. nLife Therapeutics, S.L. Major Business
Table 17. nLife Therapeutics, S.L. Huntington Disease Protein Product and Services
Table 18. nLife Therapeutics, S.L. Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. reMYND NV Basic Information, Manufacturing Base and Competitors
Table 20. reMYND NV Major Business
Table 21. reMYND NV Huntington Disease Protein Product and Services
Table 22. reMYND NV Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sangamo BioSciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 24. Sangamo BioSciences, Inc. Major Business
Table 25. Sangamo BioSciences, Inc. Huntington Disease Protein Product and Services
Table 26. Sangamo BioSciences, Inc. Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. UniQure N.V. Basic Information, Manufacturing Base and Competitors
Table 28. UniQure N.V. Major Business
Table 29. UniQure N.V. Huntington Disease Protein Product and Services
Table 30. UniQure N.V. Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Voyager Therapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Voyager Therapeutics, Inc. Major Business
Table 33. Voyager Therapeutics, Inc. Huntington Disease Protein Product and Services
Table 34. Voyager Therapeutics, Inc. Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Vybion, Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Vybion, Inc. Major Business
Table 37. Vybion, Inc. Huntington Disease Protein Product and Services
Table 38. Vybion, Inc. Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. WAVE Life Sciences Ltd. Basic Information, Manufacturing Base and Competitors
Table 40. WAVE Life Sciences Ltd. Major Business
Table 41. WAVE Life Sciences Ltd. Huntington Disease Protein Product and Services
Table 42. WAVE Life Sciences Ltd. Huntington Disease Protein Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Global Huntington Disease Protein Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 44. Global Huntington Disease Protein Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 45. Market Position of Manufacturers in Huntington Disease Protein, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 46. Global Huntington Disease Protein Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 47. Head Office and Huntington Disease Protein Production Site of Key Manufacturer
Table 48. Huntington Disease Protein New Entrant and Capacity Expansion Plans
Table 49. Huntington Disease Protein Mergers & Acquisitions in the Past Five Years
Table 50. Global Huntington Disease Protein Sales by Region (2016-2021e) & (K Pcs)
Table 51. Global Huntington Disease Protein Sales by Region (2021-2026) & (K Pcs)
Table 52. Global Huntington Disease Protein Revenue by Region (2016-2021e) & (USD Million)
Table 53. Global Huntington Disease Protein Revenue by Region (2021-2026) & (USD Million)
Table 54. Global Huntington Disease Protein Sales by Type (2016-2021e) & (K Pcs)
Table 55. Global Huntington Disease Protein Sales by Type (2021-2026) & (K Pcs)
Table 56. Global Huntington Disease Protein Revenue by Type (2016-2021e) & (USD Million)
Table 57. Global Huntington Disease Protein Revenue by Type (2021-2026) & (USD Million)
Table 58. Global Huntington Disease Protein Price by Type (2016-2021e) & (USD/Pcs)
Table 59. Global Huntington Disease Protein Price by Type (2021-2026) & (USD/Pcs)
Table 60. Global Huntington Disease Protein Sales by Application (2016-2021e) & (K Pcs)
Table 61. Global Huntington Disease Protein Sales by Application (2021-2026) & (K Pcs)
Table 62. Global Huntington Disease Protein Revenue by Application (2016-2021e) & (USD Million)
Table 63. Global Huntington Disease Protein Revenue by Application (2021-2026) & (USD Million)
Table 64. Global Huntington Disease Protein Price by Application (2016-2021e) & (USD/Pcs)
Table 65. Global Huntington Disease Protein Price by Application (2021-2026) & (USD/Pcs)
Table 66. North America Huntington Disease Protein Sales by Country (2016-2021e) & (K Pcs)
Table 67. North America Huntington Disease Protein Sales by Country (2021-2026) & (K Pcs)
Table 68. North America Huntington Disease Protein Revenue by Country (2016-2021e) & (USD Million)
Table 69. North America Huntington Disease Protein Revenue by Country (2021-2026) & (USD Million)
Table 70. North America Huntington Disease Protein Sales by Type (2016-2021e) & (K Pcs)
Table 71. North America Huntington Disease Protein Sales by Type (2021-2026) & (K Pcs)
Table 72. North America Huntington Disease Protein Sales by Application (2016-2021e) & (K Pcs)
Table 73. North America Huntington Disease Protein Sales by Application (2021-2026) & (K Pcs)
Table 74. Europe Huntington Disease Protein Sales by Country (2016-2021e) & (K Pcs)
Table 75. Europe Huntington Disease Protein Sales by Country (2021-2026) & (K Pcs)
Table 76. Europe Huntington Disease Protein Revenue by Country (2016-2021e) & (USD Million)
Table 77. Europe Huntington Disease Protein Revenue by Country (2021-2026) & (USD Million)
Table 78. Europe Huntington Disease Protein Sales by Type (2016-2021e) & (K Pcs)
Table 79. Europe Huntington Disease Protein Sales by Type (2021-2026) & (K Pcs)
Table 80. Europe Huntington Disease Protein Sales by Application (2016-2021e) & (K Pcs)
Table 81. Europe Huntington Disease Protein Sales by Application (2021-2026) & (K Pcs)
Table 82. Asia-Pacific Huntington Disease Protein Sales by Region (2016-2021e) & (K Pcs)
Table 83. Asia-Pacific Huntington Disease Protein Sales by Region (2021-2026) & (K Pcs)
Table 84. Asia-Pacific Huntington Disease Protein Revenue by Region (2016-2021e) & (USD Million)
Table 85. Asia-Pacific Huntington Disease Protein Revenue by Region (2021-2026) & (USD Million)
Table 86. Asia-Pacific Huntington Disease Protein Sales by Type (2016-2021e) & (K Pcs)
Table 87. Asia-Pacific Huntington Disease Protein Sales by Type (2021-2026) & (K Pcs)
Table 88. Asia-Pacific Huntington Disease Protein Sales by Application (2016-2021e) & (K Pcs)
Table 89. Asia-Pacific Huntington Disease Protein Sales by Application (2021-2026) & (K Pcs)
Table 90. South America Huntington Disease Protein Sales by Country (2016-2021e) & (K Pcs)
Table 91. South America Huntington Disease Protein Sales by Country (2021-2026) & (K Pcs)
Table 92. South America Huntington Disease Protein Revenue by Country (2016-2021e) & (USD Million)
Table 93. South America Huntington Disease Protein Revenue by Country (2021-2026) & (USD Million)
Table 94. South America Huntington Disease Protein Sales by Type (2016-2021e) & (K Pcs)
Table 95. South America Huntington Disease Protein Sales by Type (2021-2026) & (K Pcs)
Table 96. South America Huntington Disease Protein Sales by Application (2016-2021e) & (K Pcs)
Table 97. South America Huntington Disease Protein Sales by Application (2021-2026) & (K Pcs)
Table 98. Middle East & Africa Huntington Disease Protein Sales by Country (2016-2021e) & (K Pcs)
Table 99. Middle East & Africa Huntington Disease Protein Sales by Country (2021-2026) & (K Pcs)
Table 100. Middle East & Africa Huntington Disease Protein Revenue by Country (2016-2021e) & (USD Million)
Table 101. Middle East & Africa Huntington Disease Protein Revenue by Country (2021-2026) & (USD Million)
Table 102. Middle East & Africa Huntington Disease Protein Sales by Type (2016-2021e) & (K Pcs)
Table 103. Middle East & Africa Huntington Disease Protein Sales by Type (2021-2026) & (K Pcs)
Table 104. Middle East & Africa Huntington Disease Protein Sales by Application (2016-2021e) & (K Pcs)
Table 105. Middle East & Africa Huntington Disease Protein Sales by Application (2021-2026) & (K Pcs)
Table 106. Direct Channel Pros & Cons
Table 107. Indirect Channel Pros & Cons
Table 108. Huntington Disease Protein Typical Distributors
Table 109. Huntington Disease Protein Typical Customers
List of Figures
Figure 1. Huntington Disease Protein Picture
Figure 2. Global Huntington Disease Protein Sales Market Share by Type in 2020
Figure 3. NI-302
Figure 4. NLF-HD
Figure 5. P-301905
Figure 6. IONIS-HTTRx
Figure 7. Others
Figure 8. Global Huntington Disease Protein Sales Market Share by Application in 2020
Figure 9. Alzheimer's Disease
Figure 10. Kennedy's Disease
Figure 11. Spinocerebellar Ataxia
Figure 12. Others
Figure 13. Global Huntington Disease Protein Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Huntington Disease Protein Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Huntington Disease Protein Sales (2016-2026) & (K Pcs)
Figure 16. Global Huntington Disease Protein Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Huntington Disease Protein Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Huntington Disease Protein Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Huntington Disease Protein Market Drivers
Figure 20. Huntington Disease Protein Market Restraints
Figure 21. Huntington Disease Protein Market Trends
Figure 22. Global Huntington Disease Protein Sales Market Share by Manufacturer in 2020
Figure 23. Global Huntington Disease Protein Revenue Market Share by Manufacturer in 2020
Figure 24. Huntington Disease Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Huntington Disease Protein Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Huntington Disease Protein Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Huntington Disease Protein Sales Market Share by Region (2016-2026)
Figure 28. Global Huntington Disease Protein Revenue Market Share by Region (2016-2026)
Figure 29. North America Huntington Disease Protein Revenue (2016-2026) & (USD Million)
Figure 30. Europe Huntington Disease Protein Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Huntington Disease Protein Revenue (2016-2026) & (USD Million)
Figure 32. South America Huntington Disease Protein Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Huntington Disease Protein Revenue (2016-2026) & (USD Million)
Figure 34. Global Huntington Disease Protein Sales Market Share by Type (2016-2026)
Figure 35. Global Huntington Disease Protein Revenue Market Share by Type (2016-2026)
Figure 36. Global Huntington Disease Protein Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Huntington Disease Protein Sales Market Share by Application (2016-2026)
Figure 38. Global Huntington Disease Protein Revenue Market Share by Application (2016-2026)
Figure 39. Global Huntington Disease Protein Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Huntington Disease Protein Sales Market Share by Type (2016-2026)
Figure 41. North America Huntington Disease Protein Sales Market Share by Application (2016-2026)
Figure 42. North America Huntington Disease Protein Sales Market Share by Country (2016-2026)
Figure 43. North America Huntington Disease Protein Revenue Market Share by Country (2016-2026)
Figure 44. United States Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Huntington Disease Protein Sales Market Share by Type (2016-2026)
Figure 48. Europe Huntington Disease Protein Sales Market Share by Application (2016-2026)
Figure 49. Europe Huntington Disease Protein Sales Market Share by Country (2016-2026)
Figure 50. Europe Huntington Disease Protein Revenue Market Share by Country (2016-2026)
Figure 51. Germany Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Huntington Disease Protein Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Huntington Disease Protein Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Huntington Disease Protein Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Huntington Disease Protein Revenue Market Share by Region (2016-2026)
Figure 60. China Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Huntington Disease Protein Sales Market Share by Type (2016-2026)
Figure 67. South America Huntington Disease Protein Sales Market Share by Application (2016-2026)
Figure 68. South America Huntington Disease Protein Sales Market Share by Country (2016-2026)
Figure 69. South America Huntington Disease Protein Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Huntington Disease Protein Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Huntington Disease Protein Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Huntington Disease Protein Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Huntington Disease Protein Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Huntington Disease Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のアルツハイマー病市場 2021：企業別、地域別、種類・用途別 The Alzheimer's Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…- 世界のアルツハイマー病治療市場予測（～2024年）：企業別、地域別、種類・用途別 Alzheimer's is a chronic neurodegenerative disease that usually starts slowly and worsens over time. Scope of the Report: The global Alzheimer's Disease Treatments market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between …
- 世界のカナバン病治療薬市場 2021：企業別、地域別、種類・用途別 The Canavan Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界の性感染症治療市場 2021：企業別、地域別、種類・用途別 The Sexually Transmitted Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 世界の網膜疾患治療市場 2021：企業別、地域別、種類・用途別 The Retinal Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…